BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 1057055)

  • 1. [Treatment of 17 cases of non-lymphoblastic acute leukemia with a combination of daunorubicin, cytosine and arabinoside].
    Dini E; Barbui T; Cartei G; Chisesi T; Cazzavillan M; Battista R
    Minerva Med; 1975 Jul; 66(52):2619-2620. PubMed ID: 1057055
    [No Abstract]   [Full Text] [Related]  

  • 2. [Results in the treatment of acute granulocytic leukemias using a combination of daunorubicine-cytosine arabinoside-cyclophosphamide. Apropos of 35 cases].
    Bauters F; Plouvier B; Caulier MT; Mouton J; Goudemand M
    Lille Med; 1974 Mar; 19(3):226-31. PubMed ID: 4612276
    [No Abstract]   [Full Text] [Related]  

  • 3. [Comparison of the effects of cytosine arabinoside, cytosine arabinoside and thioguanine, and cytosine arabinoside and daunorubicin in acute myeloid leukemia].
    Malpas J; Mathé G; Hayat M
    Bull Cancer; 1974; 61(3):411-8. PubMed ID: 4533741
    [No Abstract]   [Full Text] [Related]  

  • 4. [Experiences in the treatment of acute myeloblastic leukemia and acute monocytic leukemia using cytosine arabinoside and 6-thioguanine].
    Essers U; Althof S; Ewers M
    Verh Dtsch Ges Inn Med; 1975; 81():1126-8. PubMed ID: 1065154
    [No Abstract]   [Full Text] [Related]  

  • 5. Sequencing of cytosine arabinoside (NSC-63878) and daunorubicin (NSC-82151) in acute myelogenous leukemia.
    Omura GA
    Cancer Treat Rep; 1976 May; 60(5):629-31. PubMed ID: 1068745
    [No Abstract]   [Full Text] [Related]  

  • 6. [Comparative evaluation of a combination of daunorubicin and cytosine arabinoside and that of aclarubicin and cytosine arabinoside in remission induction in acute non-lymphocytic leukemia].
    Takahashi I; Hara M; Ohmoto E; Oda Y; Endo Y; Fujimoto S; Uchida K; Takaoka K; Watanabe S; Lai M; Kohi F; Kitajima K; Kimura I; Sanada H; Tokioka M; Adachi T; Yorimitsu S
    Gan To Kagaku Ryoho; 1982 Sep; 9(9):1617-22. PubMed ID: 6964050
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combination chemotherapy of acute leukaemia in adults. Comparison of two schedules.
    Scand J Haematol; 1974; 12(5):341-5. PubMed ID: 4527707
    [No Abstract]   [Full Text] [Related]  

  • 8. Daunorubicin (NSC-82151), vincristine (NSC-67574), cytosine arabinoside (NSC-63878), and prednisone (NSC-10023) combination therapy for advanced adult acute leukemia.
    Burns CP
    Cancer Chemother Rep; 1975; 59(4):757-60. PubMed ID: 1100227
    [No Abstract]   [Full Text] [Related]  

  • 9. [Treatment of acute myeloblastic leukemia with daunorubicin and cytosine-arabinoside].
    Thorling K; Petersen HS; Jensen KB; Bastrup-Madsen P
    Ugeskr Laeger; 1972 Oct; 134(42):2201-5. PubMed ID: 4507751
    [No Abstract]   [Full Text] [Related]  

  • 10. [Treatment of acute myeloblastic leukemia with cytosine arabinoside combined with daunorubicin or ifosfamide or thioguanine].
    Büchner T; Kamanabroo D; Hiddemann W; Urbanitz D
    Verh Dtsch Ges Inn Med; 1978; (84):145-8. PubMed ID: 283634
    [No Abstract]   [Full Text] [Related]  

  • 11. [Trial treatment of acute myeloblastic leukemia with the cytosine arabinoside-cyclophosphamide association. (Apropos of 30 cases)].
    Bauters F; Lerche B; Samsoen J; Goudemand M
    Therapeutique; 1972 Apr; 48(4):303-8. PubMed ID: 4507025
    [No Abstract]   [Full Text] [Related]  

  • 12. [Clinical use of cytosine arabinoside in infancy. I. Cytosine arabinoside in the treatment of acute leukosis].
    Masi M; Vivarelli F; Paolucci P; Vecchi V
    Minerva Pediatr; 1975 Sep; 27(28):1539-50. PubMed ID: 1101022
    [No Abstract]   [Full Text] [Related]  

  • 13. Drug-induced kinetic perturbations of the marrow blasts in acute leukemia. Effects of the daunorubicin, cytosine arabinoside and 6-thioguanine combination.
    Amadori S; Petti MC; Mastrovincenzo C; Testa MG
    Acta Haematol; 1979; 61(5):237-42. PubMed ID: 111451
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Experiences with daunomycin and cytosine arabinoside in the therapy of acute myeloid leukemias].
    Kreiter H; Begemann H; Rastetter J
    Med Klin; 1968 Dec; 63(51):2058-66. PubMed ID: 5255517
    [No Abstract]   [Full Text] [Related]  

  • 15. [Treatment of therapy-resistant acute non-lymphocytic leukemia with PADOC (author's transl)].
    Yoshikawa H; Uetani T; Sako F; Yamaguchi H; Yoshikawa S; Nishiwaki H; Murakami S; Ichimiya M; Takeyama H; Ogata K; Kobayashi M; Morishima Y; Ishiguro J; Kawashima K; Kamiya T; Ohno R; Koie K; Yamada K
    Rinsho Ketsueki; 1978 Mar; 19(3):207-13. PubMed ID: 279717
    [No Abstract]   [Full Text] [Related]  

  • 16. [Treatment of acute myeloid leukemia in adults with a combination of daunomycin and cytosine-arabinoside].
    Brincker H
    Ugeskr Laeger; 1972 Oct; 134(42):2195-200. PubMed ID: 4563112
    [No Abstract]   [Full Text] [Related]  

  • 17. [1973 treatment of acute leukemias].
    Danieli G
    Minerva Med; 1974 Dec; 65(90):4742-53. PubMed ID: 4141485
    [No Abstract]   [Full Text] [Related]  

  • 18. [Therapy of acute leukemia. 4. Remission induction and remission maintenance therapy].
    Hirano M; Uetani T; Morita A; Sako F; Koie K
    Saishin Igaku; 1971 Oct; 26(10):2034-41. PubMed ID: 5288692
    [No Abstract]   [Full Text] [Related]  

  • 19. [Acute monocytic leukemia and acute myelomonocytic leukemia: treatment using VP 16213].
    Amiel JL; Schwarzenberg L; Musset M; De Vassal F; Hayat M; Mathé G
    Bull Cancer; 1974; 61(3):419-26. PubMed ID: 4533742
    [No Abstract]   [Full Text] [Related]  

  • 20. [Difficulties of remission induction treatment of acute myeloblastic leukemia].
    Fière D; Bryon PA; Martin C; Revol L
    Sem Hop; 1974 May; 50(25):1691-4. PubMed ID: 4369538
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.